Farmácia/Notícias da Indústria
Incidência de miocardite/pericardite após vacinação contra COVID-19 com vacina mRNA entre crianças e jovens adultos nos EUA.
17 Out, 2022 | 13:38hComunicado de imprensa: Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children, younger adults in the US – American College of Physicians
Comentário no Twitter (fio – clique para saber mais)
Let me me perfectly clear about the evidence for myocarditis after mRNA vaccines
1. There is a notable increased incidence, age 12-39, males, with each dose (Table)https://t.co/XXQbyeLiSP pic.twitter.com/wLTZT3fppy— Eric Topol (@EricTopol) October 12, 2022
Comentário no Twitter
Let me me perfectly clear about the evidence for myocarditis after mRNA vaccines
1. There is a notable increased incidence, age 12-39, males, with each dose (Table)https://t.co/XXQbyeLiSP pic.twitter.com/wLTZT3fppy— Eric Topol (@EricTopol) October 12, 2022
Riscos e benefícios associados à continuação de anti-TNF após 24 semanas de gestação na doença inflamatória intestinal.
17 Out, 2022 | 13:02hBenefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Anti-TNF continuation after 24 weeks of pregnancy beneficial to persons with IBD, does not affect neonatal outcomes – American College of Physicians
Comentário: Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial – HealthDay
Comentário no Twitter
10 year trial found continuation of #AntiTNF treatment after 24 weeks of pregnancy appears beneficial for #IBD activity and prematurity, not affecting neonatal outcomes and serious infections in the offspring. @EPIPHARE https://t.co/YuytSQqDsE pic.twitter.com/CRGN80K93A
— Annals of Int Med (@AnnalsofIM) September 27, 2022
M-A de rede | Eficácia comparativa de terapias de redução de lípides adicionadas a máximas doses toleradas de estatinas na redução do LDL-colesterol.
13 Set, 2022 | 11:53h
Não adesão ao tratamento foi revelada por meio de medidas da concentração sérica de medicamentos anti-hipertensivos em 1/3 dos pacientes com hipertensão resistente previamente avaliados como aderentes ao tratamento.
13 Set, 2022 | 11:51h
Resumo de diretriz | Tratamento de pacientes com alergia a antibiótico suspeita ou confirmada.
12 Set, 2022 | 11:34hConteúdos relacionados:
M-A: Most patients with allergy to Penicillin can be given Cefazolin
Podcast: A Clinical Pharmacologist’s Perspective on Penicillin Allergy
Study: Development and Validation of a Penicillin Allergy Clinical Decision Rule
NICE: Double Check Patients with ‘Penicillin Allergy’ to Avoid Increased MRSA Risk
Perspectiva | Uso de drogas psicodélicas na depressão.
12 Set, 2022 | 11:21hPsychedelic drugs take on depression – Nature
Revisão sistemática | Probióticos na prevenção de infecções agudas do trato respiratório superior.
8 Set, 2022 | 14:05hProbiotics for preventing acute upper respiratory tract infections – Cochrane Library
Comentário no Twitter
#probiotics for preventing colds? @CochraneARI looked at 24 studies w 6,950 people.
👍 may be beneficial in preventing at least 1 occurrence of acute upper respiratory tract infection #URTI & likely beneficial in preventing 3 occurrences of URTIs.https://t.co/A6XxrjKKcI pic.twitter.com/mDR3NYLLzQ— The Cochrane Library (@CochraneLibrary) August 24, 2022
Estudo levanta preocupações sobre a efetividade da vacina contra a varíola dos macacos.
8 Set, 2022 | 14:03hStudy raises concerns about the effectiveness of the monkeypox vaccine – STAT
Estudo original (preprint): Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals – medRxiv
Revisão sistemática | Tratamento com agonistas opioides para pessoas dependentes de medicamentos opioides.
8 Set, 2022 | 13:52hOpioid agonist treatment for people who are dependent on pharmaceutical opioids – Cochrane Library
Revisão | Complicações cardiovasculares dos imunoterápicos para câncer.
8 Set, 2022 | 13:40hCardiovascular complications of immune checkpoint inhibitors for cancer – European Heart Journal
Conteúdos relacionados:
Cardiotoxicity of immune checkpoint inhibitors – ESMO Open
Cardiotoxicity from immune checkpoint inhibitors – IJC Heart & Vasculature
Comentário no Twitter
Must read state-of-the-art review: Cardiovascular complications of immune checkpoint inhibitors for cancer https://t.co/0lr7g6s8g0
#EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/jORaTzP7GD— European Society of Cardiology Journals (@ESC_Journals) September 5, 2022